JAR PHARMA LTD

Company Registration Number:
12554998 (England and Wales)

Unaudited micro entity accounts for the year ended 30 April 2024

Period of accounts

Start date: 01 May 2023

End date: 30 April 2024

JAR PHARMA LTD

Contents of the Financial Statements

for the Period Ended 30 April 2024

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

JAR PHARMA LTD

Company Information

for the Period Ended 30 April 2024




Registered office: 15
St. Bernards Road
Solihull
England
B92 7AU
Company Registration Number: 12554998 (England and Wales)

JAR PHARMA LTD

Profit and Loss Account

for the Period Ended 30 April 2024


2024
£

2023
£
Turnover 193,753 163,701
Other Income 340 201
Cost of Materials ( 127,172 ) ( 73,196 )
Staff Costs ( 1,000 ) -
Depreciation and Writeoffs ( 3,050 ) -
Other charges ( 65,819 ) ( 59,797 )
Tax on Profit ( 128 ) -
Profit or (Loss) for Period ( 3,076 ) 30,909

JAR PHARMA LTD

Balance sheet

As at 30 April 2024


2024
£

2023
£
Called up share capital not paid: 0 0
Fixed Assets: 9,245 285
Current assets: 15,617 45,984
Prepayments and accrued income: 300
Creditors: amounts falling due within one year: ( 9,473 ) ( 18,505 )
Net current assets (liabilities): 6,444 27,479
Total assets less current liabilities: 15,689 27,764
Total net assets (liabilities): 15,689 27,764
Capital and reserves: 15,689 27,764

JAR PHARMA LTD

Balance sheet continued

For the year ending 30 April 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 26 January 2025
And Signed On Behalf Of The Board By:

Name: Johari Azali Razak
Status: Director

The notes form part of these financial statements

JAR PHARMA LTD

Footnotes to the Financial Statements

for the Period Ended 30 April 2024

  • 1. Employee Information

    Average number of employees: 1

JAR PHARMA LTD

Footnotes to the Financial Statements

for the Period Ended 30 April 2024

  • 2. Off balance sheet disclosure

    No

JAR PHARMA LTD

Footnotes to the Financial Statements

for the Period Ended 30 April 2024

  • 3. Advances and credits

    During the year the director’s loan account was overdrawn by £58,058, representing a loan taken by the director for working capital purposes. This loan is interest bearing at 2.25% per annum and is repayable on demand. The outstanding balance at year-end is £15,525 (prior year -£4,294), which was repaid in full on 16/12/2024.